FIRST-LINE TREATMENT CHOICE FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: WHAT DO CLINICIANS CARE ABOUT? THE CLL FITNESS STUDY

被引：0

作者：

Scarfo, L. ^{[1
,2
]}

Quaresmini, G. ^{[3
,4
]}

Ambrosetti, A. ^{[5
]}

Laurenti, L. ^{[6
]}

Rossini, F. ^{[7
,8
]}

Trentin, L. ^{[9
]}

Coscia, M. ^{[10
]}

Orlandi, E. ^{[11
]}

Mannina, D. ^{[12
]}

Torreggiani, A. ^{[13
]}

Rambaldi, A. ^{[3
,4
]}

Semenzato, G. ^{[9
]}

Innocenti, I. ^{[6
]}

Brugiatelli, M. ^{[12
]}

Cuneo, A. ^{[14
]}

Foa, R. ^{[1
,2
,3
,4
]}

Molica, S. ^{[1
,2
,5
]}

Morra, E. ^{[1
,2
,6
]}

Pane, F. ^{[1
,2
,7
,8
]}

Pizzolo, G. ^{[5
]}

Ghia, P. ^{[1
,2
]}

机构：

[1] Ist Sci San Raffaele, Dept Oncohematol, Lymphoma Unit, Milan, Italy

[2] Univ Vita Salute San Raffaele, Milan, Italy

[3] Azienda Osped Papa Giovanni XXIII, Hematol Unit, Bergamo, Italy

[4] Azienda Osped Papa Giovanni XXIII, Bone Marrow Transplant Unit, Bergamo, Italy

[5] Policlin GB Rossi, Dept Hematol, Verona, Italy

[6] Univ Cattolica Sacro Cuore, Inst Hematol, I-00168 Rome, Italy

[7] Osped San Gerardo, Div Ematol, Monza, Italy

[8] Osped San Gerardo, Ctr TMO, Monza, Italy

[9] Univ Padua, Sch Med, Dept Med, Hematol & Clin Immunol Branch, Padua, Italy

[10] Azienda Osped Univ Citta Salute & Sci Torino, Div Hematol, Turin, Italy

[11] Fdn IRCCS Policlin San Matteo, Dept Oncohematol, Hematol Unit, Pavia, Italy

[12] Osped Papardo, Div Ematol, Messina, Italy

[13] Fdn IRCCS Policlin San Matteo, Pavia, Italy

[14] Azienda Osped Univ S Anna, Sect Hematol, Ferrara, Italy

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PB1512

引用

页码：587 / 587

页数：1

共 50 条

[1] MAKING THE RIGHT CHOICE: THE ROLE OF FITNESS STATUS IN THE MANAGEMENT OF FIRST-LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL FITNESS STUDY)
Scarfo, L.
Quaresmini, G.
Mauro, F. R.
Orlandi, E.
Reda, G.
Laurenti, L.
Coscia, M.
Ambrosetti, A.
Murru, R.
Trentin, L.
Guelill, A.
Visco, C.
Morabito, F.
Frustaci, A.
Ciolli, S.
Rossini, F.
Cuneo, A.
Gozzetti, A.
Scortechini, I.
Pane, F.
Zinzani, P. L.
Ferrara, F.
Mannina, D.
Marasca, R.
Pierri, I.
Specchia, G.
Chiarenza, A.
Zallio, F.
Molica, S.
De Paoli, L.
Torreggiani, A.
Brugiatelli, M.
Semenzato, G.
Innocenti, I.
Picardi, P.
Pizzolo, G.
Foa, R.
Rambaldi, A.
Ghia, P.
HAEMATOLOGICA, 2015, 100 : 227 - 227
[2] Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)
Jain, Nitin
Keating, Michael J.
Thompson, Philip A.
Ferrajoli, Alessandra
Burger, Jan A.
Borthakur, Gautam M.
Takahashi, Koichi
Estrov, Zeev E.
Fowler, Nathan H.
Kadia, Tapan M.
Konopleva, Marina Y.
Alvarado, Yesid
Yilmaz, Musa
DiNardo, Courtney D.
Bose, Prithviraj
Ohanian, Maro
Pemmaraju, Naveen
Jabbour, Elias
Sasaki, Koji
Kanagal-Shamanna, Rashmi
Patel, Keyur
Jorgensen, Jeffrey L.
Wang, Sa A.
Garg, Naveen
Wang, Xuemei
Sondermann, Katrina
Cruz, Nichole
Wei, Chongjuan
Ayala, Ana
Plunkett, William
Kantarjian, Hagop M.
Gandhi, Varsha
Wierda, William G.
BLOOD, 2019, 134
[3] FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB IN FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): RETROSPECTIVE STUDY
Ionita, H.
Ionita, I.
Cheveresan, M.
Ionita, M.
Calamar, D.
Ionita, C. O.
Oros, D.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 526 - 526
[4] FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB IN FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): RETROSPECTIVE ANALYSIS OF CZECH CLL STUDY GROUP
Smolej, L.
Lysak, D.
Papajik, T.
Salkova, J.
Brejcha, M.
Vozobulova, V.
Karban, J.
Hrudkova, M.
Cmunt, E.
Turcsanyi, P.
Jungova, A.
Krejcova, H.
Trneny, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 373 - 373
[5] First-line treatment and outcome in patients with chronic lymphocytic leukemia (CLL) according to age: a report of the German CLL Study Group (GCLLSG) registry
Maurer, C.
Fink, A. M.
Robrecht, S.
Bahlo, J.
Fischer, K.
Eichhorst, B.
Hallek, M.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 170 - 171
[6] Chronic Lymphocytic Leukemia (CLL) The choice of a BTKl in first and second line therapy
Schmale, Ine
ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (1-2)
[7] Chronic lymphocytic Leukemia (CLL) New Options in the First Line Therapy of the CLL
Sankawa, Yuri
ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (12) : 784 - 787
[8] Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG)
Cramer, Paula
Langerbeins, Petra
Eichhorst, Barbara
Hallek, Michael
EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (01) : 9 - 18
[9] Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL): Focus on MRD Results
Jain, Nitin
Keating, Michael J.
Thompson, Philip A.
Ferrajoli, Alessandra
Burger, Jan A.
Borthakur, Gautam
Takahashi, Koichi
Estrov, Zeev E.
Sasaki, Koji
Fowler, Nathan H.
Kadia, Tapan M.
Konopleva, Marina
Alvarado, Yesid
Yilmaz, Musa
DiNardo, Courtney D.
Bose, Prithviraj
Ohanian, Maro
Pemmaraju, Naveen
Jabbour, Elias
Kanagal-Shamanna, Rashmi
Patel, Keyur
Wang, Wei
Jorgensen, Jeffrey L.
Wang, Sa A.
Garg, Naveen
Wang, Xuemei
Cruz, Nichole
Ayala, Ana
Plunkett, William
Kantarjian, Hagop M.
Gandhi, Varsha
Wierda, William G.
BLOOD, 2020, 136
[10] WHAT DO WE KNOW ABOUT THE REAL INCIDENCE OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND WHERE AND HOW ARE THE PATIENTS WITH CLL TREATED?
Panovska, A.
Doubek, M.
Brychtova, Y.
Pospisilova, S.
Mayer, J.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 600 - 600

← 1 2 3 4 5 →